Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Barlesi

Showing results (81-90 of 344) with videos related to

Pageof 35
Sort By:
Radiation Oncology (London, England)|May 30, 2012
Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessmentAgnes V Tallet, David Azria, Fabrice Barlesi, et al.
Journal of Chemotherapy (Florence, Italy)|January 1, 2019
Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practiceMarc Montana, Marie-Eve Garcia, Nathalie Ausias, et al.
Clinical Lung Cancer|October 30, 2018
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of CareJyoti D Patel, Luis Paz-Ares, Ralph G Zinner, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 11, 2003
Bronchioloalveolar carcinoma: myths and realities in the surgical managementFabrice Barlesi, Christophe Doddoli, Céline Gimenez, et al.
Cells|July 18, 2018
Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?Julien Guinde, Diane Frankel, Sophie Perrin, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 4, 2005
One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefitsChristophe Doddoli, Fabrice Barlesi, Delphine Trousse, et al.
The British Journal of Radiology|April 5, 2016
An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept studyLaetitia Padovani, Aurelie Baret, Joseph Ciccolini, et al.
Cancer Treatment Reviews|October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectivesClaudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 18, 2014
Anaphylactic reaction to pemetrexed: a case reportHéloise Capelle, Joelle Birnbaum, Pascale Tomasini, et al.
Cancer Research|June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with RadiotherapyRaphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Pageof 35

Showing results (81-90 of 344) with videos related to

Sort By:
Pageof 35
Radiation Oncology (London, England)|May 30, 2012
Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessmentAgnes V Tallet, David Azria, Fabrice Barlesi, et al.
Journal of Chemotherapy (Florence, Italy)|January 1, 2019
Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practiceMarc Montana, Marie-Eve Garcia, Nathalie Ausias, et al.
Clinical Lung Cancer|October 30, 2018
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of CareJyoti D Patel, Luis Paz-Ares, Ralph G Zinner, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 11, 2003
Bronchioloalveolar carcinoma: myths and realities in the surgical managementFabrice Barlesi, Christophe Doddoli, Céline Gimenez, et al.
Cells|July 18, 2018
Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?Julien Guinde, Diane Frankel, Sophie Perrin, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 4, 2005
One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefitsChristophe Doddoli, Fabrice Barlesi, Delphine Trousse, et al.
The British Journal of Radiology|April 5, 2016
An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept studyLaetitia Padovani, Aurelie Baret, Joseph Ciccolini, et al.
Cancer Treatment Reviews|October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectivesClaudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 18, 2014
Anaphylactic reaction to pemetrexed: a case reportHéloise Capelle, Joelle Birnbaum, Pascale Tomasini, et al.
Cancer Research|June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with RadiotherapyRaphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Pageof 35